Table of Contents
STUDY GOALS AND OBJECTIVES
This BCC Research report, Companion Diagnostics: Technologies and Markets, provides an overview of the current state of development in the companion diagnostics field, existing products on the market and detailed analysis of the competitive environments, including new potential markets for current industry trends. The study includes information regarding significant current players in this field of study, trends and challenges, as well as other information affecting assay development in this space of personalized medicine.
REASONS FOR DOING THIS STUDY
When the human genome project was finally completed in 2003, the idea of testing the specific genetic signature for every human individual became a reality. In addition to the fast development of proteomic approaches and array technology, a new trend in personalized medicine started to evolve as part of the healthcare system. Personalized medicine became more embraced by healthcare providers, the pharmaceutical industry and even insurance companies in an attempt to reduce unnecessary expenses and costs for patient treatments. The Personalized Medicine Coalition (PMC), a nonprofit advocacy group, was recently formed to keep close track of all developments and propositions arising in this field.
Companion diagnostics is part of the personalized medicine revolution. The field has evolved as a continuation of biomarker studies and diagnostic testing. This area of industry is still relatively young, but it will become more complicated and developed due to numerous successful U.S. Food and Drug Administration (FDA)-approved products.
Moreover, the companion diagnostics approach in drug development has reduced the cost of bringing new medicines and therapies to the market.
This study will provide knowledge of the current state of the companion diagnostic industry, its main market participants and new technologies in assay development. More importantly, it will describe potential novel commercial venues in this area of the healthcare industry.
SCOPE AND FORMAT
Personalized medicine is relatively new to the market research report format and provides business tools to evaluate new commercial opportunities in diagnostics and biomarker fields. The geographic scope of this study covers U.S. and global companies. The report identifies major commercial sectors in companion diagnostics, including oncology-related products versus cardiovascular diseases. It describes current products in each area, identifies current market participants, and most importantly, notes the trends that are likely to affect further product development in this area. The report also provides information regarding less-developed sectors of this market, along with a list of current companies that have new companion diagnostic products in development.
METHODOLOGY AND INFORMATION SOURCES
Both primary and secondary research methodologies were used to prepare this study. Initially, a comprehensive and exhaustive search of the literature on drug discovery and already marketed products was conducted. These secondary sources included drug discovery and science-related journals, textbooks, press releases, marketing literature, product and promotional literature, annual reports, security analyst reports and other publications. Patent searches and analyses were also conducted.
In a second phase, a series of semi-structured interviews was conducted with company representatives, bench scientists, marketing representatives and other personnel at biotechnology and pharmaceutical companies. Other sources included academic institutions and technology and consulting companies. Subsequent analysis of the documents and interview notes was iterative.
This report is intended for business development professionals, healthcare professionals, entrepreneurs and other investment groups to help them fully understand and evaluate a new, less-familiar area of the healthcare and diagnostic industry. It provides companies’ corporate development departments with new insight into competitors’ positions and shows new opportunities otherwise overlooked or unfamiliar to the public.
Dr. Marianna Tcherpakov has more than eight years experience as a bench scientist specializing in biochemistry, cell biology and industrial assay development. She has contributed to numerous scientific publications and holds several patents. She has expertise as an assay development scientist, and she is familiar with different research field trends and likely future developments.
The global companion diagnostics market reached $1.1 billion in 2012. The market is expected to grow to $1.2 billion in 2013 and $3.5 billion in 2018 with a compound annual growth rate (CAGR) of 23.9%.
This report provides:
• An overview of the market for companion diagnostics, including existing products on the market and detailed analysis of the competitive environments.
• Analyses of market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018.
• Examination of the current state of the industry, new technologies in assay development, and potential novel commercial venues in this area of the healthcare industry.
• Identification of major commercial sectors in companion diagnostics: oncology related products vs. cardiovascular diseases and other segments.
• Comprehensive company profiles of major players, as well as a list of current companies that have new companion diagnostics products in development.
Get Industry Insights. Simply.
Talk to Ahmad
+1 718 618 4302
This new 31-country report from VPGMarketResearch.com is available by country, market segment, section, or individual test. This report is designed to assist diagnostics industry executives, as well as ...
Complete report $34,500. DataPack (test volumes, sales forecasts, supplier shares) $21,100. The report is available by country, section, market segment, and can be custom-tailored to your specific ...
Complete report $34,750. DataPack (test volumes, sales forecasts, supplier shares) $21,100. The report is available by country, section, market segment, and can be custom-tailored to your specific ...